Humanwell Healthcare Group Co Ltd
SSE:600079

Watchlist Manager
Humanwell Healthcare Group Co Ltd Logo
Humanwell Healthcare Group Co Ltd
SSE:600079
Watchlist
Price: 23.48 CNY -2.29%
Market Cap: 38.3B CNY
Have any thoughts about
Humanwell Healthcare Group Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Humanwell Healthcare Group Co Ltd

Current Assets 20.1B
Cash & Short-Term Investments 3.5B
Receivables 11.1B
Other Current Assets 5.5B
Non-Current Assets 16.5B
Long-Term Investments 1.6B
PP&E 10.7B
Intangibles 3.6B
Other Non-Current Assets 633.9m
Current Liabilities 13.4B
Accounts Payable 2.8B
Accrued Liabilities 601.3m
Short-Term Debt 7.7B
Other Current Liabilities 2.3B
Non-Current Liabilities 5.9B
Long-Term Debt 1.8B
Other Non-Current Liabilities 4.1B

Balance Sheet
Humanwell Healthcare Group Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 480
2 411
3 209
4 019
3 923
3 439
4 981
5 166
4 337
3 069
Cash
2
3
4
11
5
7
3
4 866
4 337
3 069
Cash Equivalents
1 478
2 408
3 205
4 008
3 918
3 432
4 978
300
0
0
Short-Term Investments
0
0
0
0
37
593
593
934
958
945
Total Receivables
3 270
4 739
5 573
7 510
8 899
8 934
7 716
8 205
8 801
10 221
Accounts Receivables
2 497
3 778
4 545
5 535
6 779
6 878
5 886
6 757
7 528
8 114
Other Receivables
773
961
1 028
1 975
2 120
2 056
1 830
1 448
1 273
2 107
Inventory
1 251
1 722
2 197
2 643
3 222
3 410
2 622
3 127
3 421
3 619
Other Current Assets
338
452
627
781
971
886
1 061
718
1 911
1 781
Total Current Assets
6 340
9 325
11 606
14 953
17 052
17 263
16 973
18 149
19 428
19 635
PP&E Net
3 360
4 946
6 186
6 390
6 199
6 288
5 844
7 329
8 361
10 708
PP&E Gross
3 360
4 946
6 186
6 390
6 199
6 288
5 844
7 329
8 361
10 708
Accumulated Depreciation
479
827
1 104
1 237
1 581
1 974
1 879
2 608
2 919
3 396
Intangible Assets
697
867
1 839
3 266
3 067
2 870
1 843
2 653
2 753
2 584
Goodwill
959
1 380
4 497
6 475
3 799
3 795
972
1 086
974
948
Note Receivable
0
117
439
594
1 255
1 112
901
731
416
364
Long-Term Investments
777
1 467
1 763
3 593
3 902
3 564
4 990
5 356
2 693
1 672
Other Long-Term Assets
34
51
97
135
149
122
104
102
1 397
293
Other Assets
959
1 380
4 497
6 475
3 799
3 795
972
1 086
974
948
Total Assets
12 167
N/A
18 152
+49%
26 428
+46%
35 406
+34%
35 423
+0%
35 013
-1%
31 627
-10%
35 406
+12%
36 023
+2%
36 204
+1%
Liabilities
Accounts Payable
978
1 488
1 850
2 009
1 944
2 013
1 658
2 075
2 814
2 717
Accrued Liabilities
55
88
154
240
348
314
285
460
551
651
Short-Term Debt
2 628
4 396
6 522
8 790
11 014
11 309
9 161
8 399
8 075
7 578
Current Portion of Long-Term Debt
115
232
666
559
1 704
866
809
2 391
1 440
823
Other Current Liabilities
824
898
868
1 444
1 407
1 323
998
2 232
2 263
1 456
Total Current Liabilities
4 601
7 102
10 060
13 042
16 416
15 824
12 911
15 556
15 143
13 226
Long-Term Debt
1 639
1 551
3 987
5 065
3 867
4 263
5 077
3 357
1 908
1 784
Deferred Income Tax
0
0
2
341
383
453
183
247
412
378
Minority Interest
1 005
1 301
1 941
3 083
3 435
3 845
2 173
2 704
2 905
3 055
Other Liabilities
200
317
396
351
486
476
519
594
618
718
Total Liabilities
7 444
N/A
10 271
+38%
16 386
+60%
21 882
+34%
24 586
+12%
24 861
+1%
20 863
-16%
22 457
+8%
20 986
-7%
19 161
-9%
Equity
Common Stock
529
1 286
1 286
1 354
1 354
1 354
1 544
1 633
1 633
1 632
Retained Earnings
2 154
2 711
3 415
5 282
2 621
3 452
4 511
5 492
7 684
9 847
Additional Paid In Capital
2 033
3 872
3 908
4 941
4 882
4 899
5 245
6 191
5 745
5 674
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
59
212
18
Treasury Stock
0
0
0
0
0
50
500
319
182
88
Other Equity
7
11
1 432
1 947
1 981
498
36
107
54
40
Total Equity
4 723
N/A
7 881
+67%
10 041
+27%
13 524
+35%
10 837
-20%
10 152
-6%
10 764
+6%
12 948
+20%
15 037
+16%
17 044
+13%
Total Liabilities & Equity
12 167
N/A
18 152
+49%
26 428
+46%
35 406
+34%
35 423
+0%
35 013
-1%
31 627
-10%
35 406
+12%
36 023
+2%
36 204
+1%
Shares Outstanding
Common Shares Outstanding
1 058
1 286
1 286
1 354
1 354
1 350
1 520
1 632
1 631
1 631

See Also

Discover More